Kessel David
Department of Pharmacology, Wayne State University School of Medicine, Detroit, MI 48201, USA.
Photochem Photobiol Sci. 2015 Aug;14(8):1397-402. doi: 10.1039/c4pp00413b. Epub 2015 Jan 5.
Failure of neoplastic cells to respond to conventional chemotherapy is usually associated with factors that limit access of drugs to subcellular sites, differences in cell-cycle kinetics or mutations leading to loss of drug-activation pathways or other processes that govern response factors. For PDT, efficacy depends mainly on selective uptake of photosensitizers by neoplastic cells, oxygenation levels, the suitable direction of irradiation and the availability of pathways to cell death that are highly conserved among mammalian cell types. While it is possible to engineer PDT-resistant cell types, current evidence suggests that the major obstacles to cancer control relate to drug, light and oxygen distribution. This review discusses some of the factors that can govern PDT-induced cell death.
肿瘤细胞对传统化疗无反应通常与限制药物进入亚细胞位点的因素、细胞周期动力学差异或导致药物激活途径丧失的突变或其他控制反应因素的过程有关。对于光动力疗法(PDT),疗效主要取决于肿瘤细胞对光敏剂的选择性摄取、氧合水平、合适的照射方向以及哺乳动物细胞类型中高度保守的细胞死亡途径的可用性。虽然有可能构建对PDT耐药的细胞类型,但目前的证据表明,癌症控制的主要障碍与药物、光和氧的分布有关。本综述讨论了一些可控制PDT诱导细胞死亡的因素。